<code id='D25EEC5656'></code><style id='D25EEC5656'></style>
    • <acronym id='D25EEC5656'></acronym>
      <center id='D25EEC5656'><center id='D25EEC5656'><tfoot id='D25EEC5656'></tfoot></center><abbr id='D25EEC5656'><dir id='D25EEC5656'><tfoot id='D25EEC5656'></tfoot><noframes id='D25EEC5656'>

    • <optgroup id='D25EEC5656'><strike id='D25EEC5656'><sup id='D25EEC5656'></sup></strike><code id='D25EEC5656'></code></optgroup>
        1. <b id='D25EEC5656'><label id='D25EEC5656'><select id='D25EEC5656'><dt id='D25EEC5656'><span id='D25EEC5656'></span></dt></select></label></b><u id='D25EEC5656'></u>
          <i id='D25EEC5656'><strike id='D25EEC5656'><tt id='D25EEC5656'><pre id='D25EEC5656'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:66831
          The logo of Neurocrine Biosciences on a phone screen with stocks chart in the background — coverage from STAT
          Neurocrine Biosciences decided to join PhRMA. Adobe

          WASHINGTON — Neurocrine Biosciences, a biotech company based in California, has joined the drug lobbying organization PhRMA, the group announced on Thursday.

          The addition is a step toward rebuilding PhRMA’s ranks after high-profile departures that followed the passage of Democrats’ drug pricing law, though both Neurocrine and the other company that joined since are smaller than those that exited.

          advertisement

          The company is a relatively big spender on lobbying, especially for its size. Neurocrine spent $3.1 million on its federal advocacy efforts last year alone. Compare that with Vertex Pharmaceuticals, which spent virtually the same amount on lobbying, even as it brought in nearly quadruple the net income that Neurocrine Biosciences did last year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Vertex non
          Vertex non

          ScientistsChristinaFreyandPaulNegulescuworkinalabatVertexPharmaceuticalsinSanDiego.SandyHuffakerforS

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          How generative AI ratchets up security threats for health systems

          AdobeTheubiquityofAItoolslikeChatGPTcouldbeaboontohospitalseagerfordiagnosticaidsoradministrativeass